卵巢细胞线粒体动力学变化与多囊卵巢综合征

doi:10.12280/gjfckx.20200838

国际妇产科学杂志 ›› 2021, Vol. 48 ›› Issue (4): 403-408.doi: 10.12280/gjfckx.20200838

• 普通妇科疾病及相关研究综述 • 上一篇下一篇

卵巢细胞线粒体动力学变化与多囊卵巢综合征

李威, 樊锐锋, 徐邱鸿, 陈静, 吴效科, 匡洪影, 王英骥, 李妍^△()

150040 哈尔滨,黑龙江中医药大学附属第一医院妇一科（李威,吴效科）,妇二科（匡洪影）,外二科（陈静）,中医转化医学研究中心（李妍）;黑龙江中医药大学药用植物学系（樊锐锋）;黑龙江省医院妇科（徐邱鸿）;哈尔滨医科大学药学院无机化学与物理化学教研室（王英骥）

收稿日期:2020-09-08 出版日期:2021-08-15 发布日期:2021-09-01
通讯作者: 李妍 E-mail:liyantcm@163.com
基金资助:
国家自然科学基金(81804139);黑龙江省中医药科研项目(ZHY2020-126);黑龙江省博士后科研启动金(LBH-Q18119);黑龙江中医药大学科研基金(2018jc05)

Mitochondrial Dynamics of Ovarian Cells and Polycystic Ovary Syndrome

LI Wei, FAN Rui-feng, XU Qiu-hong, CHEN Jing, WU Xiao-ke, KUANG Hong-ying, WANG Ying-ji, LI Yan^△()

The First Department of Gynecology (LI Wei, WU Xiao-ke), The Second Department of Gynecology (KUANG Hong-ying), The Second Department of Surgery (CHEN Jing), Translational Medicine Center of Traditional Chinese Medicine (LI Yan), The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China; Department of Medicinal Botany, Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China (FAN Rui-feng); Department of Gynecology, Heilongjiang Provincial Hospital, Harbin 150036, China (XU Qiu-hong); Department of Inorganic Chemistry and Physical Chemistry, College of Pharmacy, Harbin Medical University, Harbin 150081, China (WANG Ying-ji)

Received:2020-09-08 Published:2021-08-15 Online:2021-09-01
Contact: LI Yan E-mail:liyantcm@163.com

摘要/Abstract

摘要：

多囊卵巢综合征（polycystic ovary syndrome,PCOS）是常见的女性内分泌疾病之一。PCOS患者颗粒细胞中调节线粒体动力学平衡关键因子表达水平的异常,提示PCOS患者卵巢细胞清除功能异常,线粒体的能力降低。卵巢细胞中异常线粒体的积聚不仅会影响细胞的胰岛素敏感性及甾体激素合成能力,还会直接降低卵泡细胞维持卵子发育的能力。而卵细胞中线粒体功能异常则会对卵子的发育潜能产生直接的负面影响。PCOS患者卵巢细胞胰岛素信号通路异常可能干扰卵巢细胞及卵细胞的线粒体动力学平衡,引起功能异常线粒体在细胞内积累,进而引起细胞内线粒体功能的异常。推测PCOS患者卵巢细胞线粒体动力学平衡的异常与PCOS患者生殖功能异常之间存在密切联系,并可能是PCOS患者胰岛素抵抗与卵巢功能异常的关键节点,但针对这一机制开发的临床治疗方案还有待进一步的深入研究。

关键词: 多囊卵巢综合征, 线粒体动力学, 磷酸肌醇3-激酶类, 代谢综合征, 哺乳动物雷帕霉素靶蛋白

Abstract:

Polycystic ovary syndrome (PCOS) is one of the endocrine diseases in women. The aberrant expression of key factors regulating mitochondrial dynamic balance found in granulosa cells of PCOS patients suggested reduced ability of ovarian cells to clear mitochondria with abnormal function. The accumulation of abnormal mitochondria in ovarian cells not only affect the insulin sensitivity and steroid hormone synthesis ability of cells, but also directly reduce the ability of follicle cells to support oocyte development. The abnormal insulin signaling pathway within ovarian cells of PCOS patients may cause abnormal mitochondrial accumulation in cells by interfering the mitochondrial dynamic of ovarian cells and oocytes. We speculated the abnormal mitochondrial dynamic of ovarian cells might relate to the abnormal reproductive function in PCOS patients and that may be the key node between insulin resistance and the abnormal ovarian function in PCOS patients, however, the development of clinical treatment based on this mechanism still need further research.

Key words: Polycystic ovary syndrome, Mitochondrial dynamics, Phosphatidylinositol 3-kinases, Metabolic syndrome, Mammalian target of rapamyoin

李威, 樊锐锋, 徐邱鸿, 陈静, 吴效科, 匡洪影, 王英骥, 李妍. 卵巢细胞线粒体动力学变化与多囊卵巢综合征[J]. 国际妇产科学杂志, 2021, 48(4): 403-408.

LI Wei, FAN Rui-feng, XU Qiu-hong, CHEN Jing, WU Xiao-ke, KUANG Hong-ying, WANG Ying-ji, LI Yan. Mitochondrial Dynamics of Ovarian Cells and Polycystic Ovary Syndrome[J]. Journal of International Obstetrics and Gynecology, 2021, 48(4): 403-408.

参考文献 35

[1]	Banaszewska B, Pawelczyk L, Spaczynski R. Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome[J]. Reprod Biol, 2019, 19(4):309-315. doi: 10.1016/j.repbio.2019.09.006. doi: S1642-431X(19)30206-2 pmid: 31606349
[2]	Ilie IR. Advances in PCOS Pathogenesis and Progression-Mitochondrial Mutations and Dysfunction[J]. Adv Clin Chem, 2018, 86(3):127-155. doi: 10.1016/bs.acc.2018.05.003. doi: 10.1016/bs.acc.2018.05.003
[3]	Salehi R, Mazier HL, Nivet AL, et al. Ovarian mitochondrial dynamics and cell fate regulation in an androgen-induced rat model of polycystic ovarian syndrome[J]. Sci Rep, 2020, 10(1):1021. doi: 10.1038/s41598-020-57672-w. doi: 10.1038/s41598-020-57672-w pmid: 31974436
[4]	Mitra K, Rikhy R, Lilly M, et al. DRP1-dependent mitochondrial fission initiates follicle cell differentiation during Drosophila oogenesis[J]. J Cell Biol, 2012, 197(4):487-497. doi: 10.1083/jcb.201110058. doi: 10.1083/jcb.201110058
[5]	Zhang M, Bener MB, Jiang Z, et al. Mitofusin 1 is required for female fertility and to maintain ovarian follicular reserve[J]. Cell Death Dis, 2019, 10(8):560. doi: 10.1038/s41419-019-1799-3. doi: 10.1038/s41419-019-1799-3 pmid: 31332167
[6]	张敏, 杜馨, 李贝贝, 等. 卵母细胞线粒体DNA与胚胎质量的相关性研究进展[J]. 国际生殖健康/计划生育杂志, 2020, 39(6):486-489.
[7]	López-Lluch G. Mitochondrial activity and dynamics changes regarding metabolism in ageing and obesity[J]. Mech Ageing Dev, 2017, 162:108-121. doi: 10.1016/j.mad.2016.12.005. doi: S0047-6374(16)30104-X pmid: 27993601
[8]	Udagawa O, Ishihara T, Maeda M, et al. Mitochondrial fission factor Drp1 maintains oocyte quality via dynamic rearrangement of multiple organelles[J]. Curr Biol, 2014, 24(20):2451-2458. doi: 10.1016/j.cub.2014.08.060. doi: 10.1016/j.cub.2014.08.060 pmid: 25264261
[9]	Luan G, Li G, Ma X, et al. Dexamethasone-Induced Mitochondrial Dysfunction and Insulin Resistance-Study in 3T3-L1 Adipocytes and Mitochondria Isolated from Mouse Liver[J]. Molecules, 2019, 24(10):1982. doi: 10.3390/molecules24101982. doi: 10.3390/molecules24101982
[10]	Fazakerley DJ, Chaudhuri R, Yang P, et al. Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance[J]. Elife, 2018, 7:e32111. doi: 10.7554/eLife.32111. doi: 10.7554/eLife.32111
[11]	Bañuls C, Rovira-Llopis S, Martinez de Marañon A, et al. Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS[J]. Metabolism, 2017, 71:153-162. doi: 10.1016/j.metabol.2017.02.012. doi: 10.1016/j.metabol.2017.02.012
[12]	Ding Y, Xia BH, Zhang CJ, et al. Mitochondrial tRNA(Leu(UUR)) C3275T, tRNA(Gln) T4363C and tRNA(Lys) A8343G mutations may be associated with PCOS and metabolic syndrome[J]. Gene, 2018, 642:299-306. doi: 10.1016/j.gene.2017.11.049. doi: S0378-1119(17)31013-2 pmid: 29155328
[13]	Rogowicz-Frontczak A, Majchrzak A, Zozulińska-Ziółkiewicz D. Insulin resistance in endocrine disorders-treatment options[J]. Endokrynol Pol, 2017, 68(3):334-351. doi: 10.5603/EP.2017.0026. doi: 10.5603/EP.2017.0026 pmid: 28660991
[14]	Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypojournal of PCOS as Functional Ovarian Hyperandrogenism Revisited[J]. Endocr Rev, 2016, 37(5):467-520. doi: 10.1210/er.2015-1104. doi: 10.1210/er.2015-1104 pmid: 27459230
[15]	Karuputhula NB, Chattopadhyay R, Chakravarty B, et al. Oxidative status in granulosa cells of infertile women undergoing IVF[J]. Syst Biol Reprod Med, 2013, 59(2):91-98. doi: 10.3109/19396368.2012.743197. doi: 10.3109/19396368.2012.743197 pmid: 23278116
[16]	Jia L, Zeng Y, Hu Y, et al. Homocysteine impairs porcine oocyte quality via deregulation of one-carbon metabolism and hypermethylation of mitochondrial DNA?[J]. Biol Reprod, 2019, 100(4):907-916. doi: 10.1093/biolre/ioy238. doi: 10.1093/biolre/ioy238
[17]	Randriamboavonjy V, Mann WA, Elgheznawy A, et al. Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity[J]. Thromb Haemost, 2015, 114(3):569-578. doi: 10.1160/TH14-09-0797. doi: 10.1160/TH14-09-0797
[18]	Abbade J, Klemetti MM, Farrell A, et al. Increased placental mitochondrial fusion in gestational diabetes mellitus: an adaptive mechanism to optimize feto-placental metabolic homeostasis?[J]. BMJ Open Diabetes Res Care, 2020, 8(1):e000923. doi: 10.1136/bmjdrc-2019-000923. doi: 10.1136/bmjdrc-2019-000923
[19]	Zimmermann M, Reichert AS. How to get rid of mitochondria: crosstalk and regulation of multiple mitophagy pathways[J]. Biol Chem, 2017, 399(1):29-45. doi: 10.1515/hsz-2017-0206. doi: 10.1515/hsz-2017-0206 pmid: 28976890
[20]	Atef MM, Abd-Ellatif RN, Emam MN, et al. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS)[J]. Arch Biochem Biophys, 2019, 671:245-254. doi: 10.1016/j.abb.2019.06.009. doi: 10.1016/j.abb.2019.06.009
[21]	Qi L, Liu B, Chen X, et al. Single-Cell Transcriptomic Analysis Reveals Mitochondrial Dynamics in Oocytes of Patients With Polycystic Ovary Syndrome[J]. Front Genet, 2020, 11:396. doi: 10.3389/fgene.2020.00396. doi: 10.3389/fgene.2020.00396
[22]	Gao T, Zhang X, Zhao J, et al. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer[J]. Cancer Lett, 2020, 469:89-101. doi: 10.1016/j.canlet.2019.10.029. doi: 10.1016/j.canlet.2019.10.029
[23]	Yao X, Zhang J, Jing X, et al. Fibroblast growth factor 18 exerts anti-osteoarthritic effects through PI3K-AKT signaling and mitochondrial fusion and fission[J]. Pharmacol Res, 2019, 139:314-324. doi: 10.1016/j.phrs.2018.09.026. doi: 10.1016/j.phrs.2018.09.026
[24]	He T, Liu Y, Zhao S, et al. Comprehensive assessment the expression of core elements related to IGFIR/PI3K pathway in granulosa cells of women with polycystic ovary syndrome[J]. Eur J Obstet Gynecol Reprod Biol, 2019, 233:134-140. doi: 10.1016/j.ejogrb.2018.12.010. doi: 10.1016/j.ejogrb.2018.12.010
[25]	Morita M, Prudent J, Basu K, et al. mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1[J]. Mol Cell, 2017, 67（6）:922-935.e5. doi: 10.1016/j.molcel.2017.08.013. doi: 10.1016/j.molcel.2017.08.013
[26]	Porta C, Paglino C, Mosca A. Targeting PI3K/Akt/mTOR Signaling in Cancer[J]. Front Oncol, 2014, 4:64. doi: 10.3389/fonc.2014.00064. doi: 10.3389/fonc.2014.00064
[27]	Song WJ, Shi X, Zhang J, et al. Akt-mTOR Signaling Mediates Abnormalities in the Proliferation and Apoptosis of Ovarian Granulosa Cells in Patients with Polycystic Ovary Syndrome[J]. Gynecol Obstet Invest, 2018, 83(2):124-132. doi: 10.1159/000464351. doi: 10.1159/000464351
[28]	Yaba A, Demir N. The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS)[J]. J Ovarian Res, 2012, 5(1):38. doi: 10.1186/1757-2215-5-38. doi: 10.1186/1757-2215-5-38
[29]	Luo QY, Huo P, Wang LL, et al. The influencing mechanism of mTOR signal pathway mediated by mitofusin-2 in development of follicle[J]. Eur Rev Med Pharmacol Sci, 2018, 22(8):2212-2217. doi: 10.26355/eurrev_201804_14806. doi: 10.26355/eurrev_201804_14806
[30]	Zhang J, Liu W, Sun X, et al. Inhibition of mTOR Signaling Pathway Delays Follicle Formation in Mice[J]. J Cell Physiol, 2017, 232(3):585-595. doi: 10.1002/jcp.25456. doi: 10.1002/jcp.25456 pmid: 27301841
[31]	Jamilian M, Samimi M, Mirhosseini N, et al. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome[J]. J Affect Disord, 2018, 238:32-38. doi: 10.1016/j.jad.2018.05.027. doi: 10.1016/j.jad.2018.05.027
[32]	Safaei Z, Bakhshalizadeh SH, Nasr Esfahani MH, et al. Effect of Vitamin D3 on Mitochondrial Biogenesis in Granulosa Cells Derived from Polycystic Ovary Syndrome[J]. Int J Fertil Steril, 2020, 14(2):143-149. doi: 10.22074/ijfs.2020.6077. doi: 10.22074/ijfs.2020.6077 pmid: 32681627
[33]	Kyei G, Sobhani A, Nekonam S, et al. Assessing the effect of MitoQ(10) and Vitamin D3 on ovarian oxidative stress, steroidogenesis and histomorphology in DHEA induced PCOS mouse model[J]. Heliyon, 2020, 6(7):e04279. doi: 10.1016/j.heliyon.2020.e04279. doi: 10.1016/j.heliyon.2020.e04279
[34]	Cheng H, Gang X, Liu Y, et al. Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes[J]. Am J Physiol Endocrinol Metab, 2020, 318(5):E750-E764. doi: 10.1152/ajpendo.00179.2019. doi: 10.1152/ajpendo.00179.2019
[35]	Skov V, Glintborg D, Knudsen S, et al. Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynjournal in skeletal muscle in polycystic ovary syndrome[J]. PLoS One, 2008, 3(6):e2466. doi: 10.1371/journal.pone.0002466. doi: 10.1371/journal.pone.0002466

卵巢细胞线粒体动力学变化与多囊卵巢综合征

Mitochondrial Dynamics of Ovarian Cells and Polycystic Ovary Syndrome

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 35

相关文章 15

编辑推荐

Metrics

本文评价

[1]	徐淑颖, 徐海鹏, 王丽娜, 张阳. 锌与多囊卵巢综合征的关系[J]. 国际妇产科学杂志, 2025, 52(2): 217-221.
[2]	闫辉波, 张琳. 1990—2021年中国及全球多囊卵巢综合征疾病负担及预测分析[J]. 国际妇产科学杂志, 2025, 52(2): 228-233.
[3]	齐丹丹, 朱海英, 曹海汝, 张跃敏. 线粒体功能障碍调控卵巢衰老的机制[J]. 国际妇产科学杂志, 2025, 52(1): 61-65.
[4]	张栋, 王筝, 李凯, 卞文丽, 高志华. 非妊娠期重度自发性卵巢过度刺激综合征一例[J]. 国际妇产科学杂志, 2025, 52(1): 79-83.
[5]	胡蝶, 任佳杰, 刘佳宁, 冯晓玲. MAPK信号通路在PCOS中的作用机制及中药单体的药理研究进展[J]. 国际妇产科学杂志, 2024, 51(6): 684-691.
[6]	李东楠, 向蓉, 汪海洋, 孙淼. 卵巢颗粒细胞凋亡在多囊卵巢综合征中的调控机制及中医药干预研究进展[J]. 国际妇产科学杂志, 2024, 51(6): 692-697.
[7]	李晨曦, 范梦笑, 吴林玲, 窦真, 贾佳, 孙娅瑄. 高雄激素诱导多囊卵巢综合征神经内分泌紊乱的研究进展[J]. 国际妇产科学杂志, 2024, 51(6): 698-702.
[8]	张益田, 李小丽. 线粒体在子宫内膜癌中的作用及治疗[J]. 国际妇产科学杂志, 2024, 51(4): 375-379.
[9]	王雅慧, 王艳, 王艳, 裴飞. 胎儿生长受限的病因及对患儿远期健康的影响[J]. 国际妇产科学杂志, 2024, 51(2): 152-156.
[10]	孙艺文, 熊可, 张梓絮, 翁雅婧, 王勇. 双酚A对多囊卵巢综合征发病机制的影响[J]. 国际妇产科学杂志, 2023, 50(6): 601-605.
[11]	李振英, 孙晓彤, 邢广阳, 李晶晶, 柳婷婷, 张一凡. 鞘脂代谢与妇科良恶性疾病的研究进展[J]. 国际妇产科学杂志, 2023, 50(6): 649-654.
[12]	徐惠, 解秀珍. 多囊卵巢综合征患者负性情绪的研究进展[J]. 国际妇产科学杂志, 2023, 50(5): 530-534.
[13]	寇丽辉, 宋殿荣, 郭洁. 负性情绪对多囊卵巢综合征不孕症的影响[J]. 国际妇产科学杂志, 2023, 50(5): 535-539.
[14]	高雅, 鲁娣, 宋殿荣. 抗苗勒管激素在多囊卵巢综合征发病及诊治中的作用[J]. 国际妇产科学杂志, 2023, 50(5): 540-544.
[15]	王磊, 张宁. 肠道微生物群失调对多囊卵巢综合征的影响[J]. 国际妇产科学杂志, 2023, 50(3): 256-260.